BioNexus Gene Lab Corp Company Profile
NASDAQ: BGLCHealth CareMedical SpecialitiesUSD
1.34+0.085 (+6.77%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BioNexus Gene Lab at a glance
BioNexus Gene Lab Corp (NASDAQ: BGLC) is a Medical Specialities company in the Health Care sector. At a market capitalization of $3.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001737523, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- BioNexus Gene Lab Corp
- Ticker
- NASDAQ: BGLC
- Sector
- Health Care
- Industry
- Medical Specialities
- Headquarters
- Malaysia
- Market cap
- $3.93M
- SEC CIK
- 0001737523
Companies similar to BioNexus Gene Lab
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ACONAclarion Inc. | 2.35 | +2.40% | $6.77M | vs BGLC |
| AMSAmerican Shared Hospital Services | 1.35 | -2.17% | $8.98M | vs BGLC |
| ADVBAdvanced Biomed Inc. | 6.21 | -2.66% | $10.26M | vs BGLC |
| ACHAccendra Health Inc. | 0.4729 | +1.46% | $36.37M | vs BGLC |
| MDXHMDxHealth SA | 0.5998 | -0.02% | $57.23M | vs BGLC |
| SERASera Prognostics Inc. Class A | 2.07 | +0.98% | $81.66M | vs BGLC |
| KEQUKewaunee Scientific Corporation | 33.84 | +0.53% | $97.98M | vs BGLC |
| BNRBurning Rock Biotech Limited ADR | 15.18 | -5.77% | $160.09M | vs BGLC |